| 000 | 05907cam a2200457 a 4500 | ||
|---|---|---|---|
| 999 |
_c12784 _d12784 |
||
| 001 | 710813028 | ||
| 003 | OCoLC | ||
| 005 | 20210927090001.0 | ||
| 008 | 110329t20122012paua b 001 0 eng | ||
| 010 | _a2011013529 | ||
| 020 | _a9781608311514 | ||
| 020 | _a1608311511 | ||
| 040 |
_aDNLM/DLC _beng _cDLC _dYDX _dNLM _dYDXCP _dUKMGB _dCDX _dEEK _dBDX _dTTU _dOCLCF _dKSU _dUtOrBLW |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRM125 _b.N83 2012 |
| 060 | 0 | 0 | _a2011 L-555 |
| 060 | 1 | 0 | _aWB 330 |
| 082 | 0 | 0 |
_a615.58 _222 |
| 100 | 1 | _aAschenbrenner, Diane S | |
| 245 | 1 | 0 |
_aDrug therapy in nursing / _cDiane S. Aschenbrenner, Samantha J. Venable |
| 250 | _aFourth edition | ||
| 264 | 1 |
_aPhiladelphia : _bWolters Kluwer Health/Lippincott Williams & Wilkins, _c[2012] |
|
| 264 | 4 | _c℗♭2012 | |
| 300 |
_axvii, 1,346 pages : _bcolor illustrations ; _c29 cm |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | 0 |
_gunit 1. _tFoundations for drug therapy in nursing. Nursing management of drug therapy / _rDiane S. Aschenbrenner -- _tPharmaceuticals: development, safeguards, and delivery / _rSamantha J. Venable -- _tDrug administration / _rDiane S. Aschenbrenner -- _gunit 2. _tCore drug knowledge. Pharmacotherapeutics, pharmacokinetics, and pharmacodynamics / _rDiane S. Aschenbrenner -- _tAdverse effects and drug interactions / _rDiane S. Aschenbrenner -- _gunit 3. _tCore patient variables. Life span: children / _rDiane S. Aschenbrenner -- _tLife span: pregnant or breast-feeding women / _rDiane S. Aschenbrenner -- _tLife span: older adults / _rDiane S. Aschenbrenner -- _tLifestyle: substance abuse / _rSamantha J. Venable -- _tLifestyle, diet, and habits: nutrition and complementary medications / _rSamantha J. Venable -- _tEnvironmental: influences on drug therapy / _rSanantha J. Venable -- _tCulture: considerations in drug therapy / _rDiane S. Aschenbrenner -- _gunit 4. _tPeripheral nervous system drugs. Drugs affecting adrenergic function / _rDiane S. Aschenbrenner and Samantha J. Venable -- _tDrugs affecting cholinergic function / _rDiane S. Aschenbrenner and Samantha J. Venable -- _gunit 5. _tCentral nervous system drugs. Drugs relieving anxiety and promoting sleep / _rBarbara G. Huggins -- _tDrugs treating mood disorders / _rBarbara G. Huggins -- _tDrugs treating psychotic disorders and dementia / _rFaye Bembry and Diane S. Aschenbrenner -- _tDrugs treating seizure disorders / _rDiane S. Aschenbrenner -- _tDrugs producing anesthesia and neuromuscular blocking / _rAndrew R. Benson -- _tDrugs affecting muscle spasm and spasticity / _rAndrew R. Benson and Kelly A. Stauffacher -- _tDrugs treating Parkinson disease and other movement disorders / _rSamantha J. Venable and Peggy Jenkins -- _tDrugs stimulating the central nervous system / _rSamantha J. Venable and Jacqueline Gilreath -- _gunit 6. _tAnalgesic and anti-inflammatory drugs. Drugs treating severe pain / _rPaul L. Sacamano and Diane S. Aschenbrenner -- _tDrugs treating mild to moderate pain, fever, inflammation, and migraine headache / _rSamantha J. Venable -- _tDrugs treating rheumatoid arthritis and gout / _rSamantha J. Venable -- |
| 505 | 0 | 0 |
_gunit 7. _tHematopoietic, cardiovascular and renal system drugs. Drugs affecting blood pressure / _rDiane S. Aschenbrenner -- _tDrugs affecting urinary output / _rDiane S. Aschenbrenner -- _tDrugs affecting lipid levels / _rDiane S. Aschenbrenner -- _tDrugs treating heart failure / _rDiane S. Aschenbrenner -- _tDrugs treating angina / _rDiane S. Aschenbrenner -- _tDrugs affecting cardiac rhythm / _rNancy Sullivan -- _tDrugs affecting coagulation / _rDiane S. Aschenbrenner -- _tDrugs affecting hematopoiesis / _rDiane S. Aschenbrenner -- _gunit 8. _tRespiratory system drugs. Drugs affecting the upper respiratory system / _rSamantha J. Venable -- _tDrugs affecting the lower respiratory system / _rSamantha J. Venable -- _gunit 9. _tGastrointestinal tract drugs. Drugs affecting the upper gastrointestinal tract / _rSamantha J. Venable and Janice J. Hoffman -- _tDrugs affecting the lower gastrointestinal tract / _rSamantha J. Venable and Janice J. Hoffman -- _gunit 10. _tAntimicrobial drugs. Principles of antimicrobial therapy / _rSamantha J. Venable -- _tAntibiotics affecting the bacterial cell wall / _rSamantha J. Venable -- _tAntibiotics affecting protein synthesis / _rSamantha J. Venable -- _tDrugs that are miscellaneous antibiotics / _rSamantha J. Venable -- _tDrugs treating urinary tract infections / _rSamantha J. Venable -- _tDrugs treating mycobacterial infections / _rSamantha J. Venable -- _tDrugs treating fungal infections / _rSamantha J. Venable -- _tDrugs treating viral infections / _rSamantha J. Venable -- _tDrugs treating HIV infection and AIDS / _rSamantha J. Venable and Gerry M. deJesus -- _tDrugs treating parasitic infections / _rSamantha J. Venable -- _gunit 11. _tEndocrine drugs. Drugs affecting corticosteroid levels / _rSamantha J. Venable and Gerry M. deJesus -- _tDrugs affecting blood glucose levels / _rDiane S. Aschenbrenner -- _tDrugs affecting pituitary, thyroid, parathyroid, and hypothalamic function / _rJoyce B. Vazaano -- _tDrugs affecting men's health and sexuality / _rDonna Rane-Szostak -- _tDrugs affecting women's health and sexuality / _rAnne B. Woods -- _tDrugs affecting uterine motility / _rAnne B. Woods -- _gunit 12. _tImmune system and cancer chemotherapy drugs. Drugs affecting the immune response / _rBrenda K. Shelton -- _tTargeted therapies / _rBrenda K. Shelton and Mikaela Olsen -- _tDrugs that are cell cycle-specific / _rMikaela Olsen -- _tDrugs that are cell cycle-nonspecific / _rMikaela Olsen |
| 600 | _2Drug | ||
| 650 | 0 | _aChemotherapy | |
| 650 | 0 | _aPharmacology | |
| 650 | 0 | _aNursing | |
| 650 | 1 | 2 | _aDrug Therapy |
| 650 | 2 | 2 | _aPharmaceutical Preparations |
| 650 | 2 | 2 | _aPharmacology |
| 655 | 2 | _aNurses' Instruction | |
| 700 | 1 | _aVenable, Samantha J | |
| 942 |
_2ddc _cBK |
||